{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:20:08Z","timestamp":1781526008653,"version":"3.54.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009699","name":"Fondazione Generali The Human Safety Net Onlus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110170","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:44:15Z","timestamp":1727397855000},"page":"110170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-3923","authenticated-orcid":false,"given":"Marco","family":"Emili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2226-7844","authenticated-orcid":false,"given":"Fiorenza","family":"Stagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Angelozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1640-0995","authenticated-orcid":false,"given":"Renata","family":"Bartesaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110170_bib1","first-page":"95","article-title":"Postnatal development of the hippocampal dentate gyrus under normal and experimental conditions","volume":"vol. 1","author":"Altman","year":"1975"},{"key":"10.1016\/j.neuropharm.2024.110170_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cne.903010304","article-title":"Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods","volume":"301","author":"Altman","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cne.903010302","article-title":"Mosaic organization of the hippocampal neuroepithelium and the multiple germinal sources of dentate granule cells","volume":"301","author":"Altman","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib4","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1523\/JNEUROSCI.3457-10.2010","article-title":"NMDA-mediated regulation of DSCAM dendritic local translation is lost in a mouse model of Down's syndrome","volume":"30","author":"Alves-Sampaio","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(07)63001-5","article-title":"The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)","volume":"163","author":"Amaral","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110170_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0306-4522(89)90424-7","article-title":"The three-dimensional organization of the hippocampal formation: a review of anatomical data","volume":"31","author":"Amaral","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110170_bib7","series-title":"The Rat Nervous System","first-page":"443","article-title":"Hippocampal formation","author":"Amaral","year":"1995"},{"key":"10.1016\/j.neuropharm.2024.110170_bib8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2174\/1574888X16666210907141447","article-title":"Regulation of neurogenesis and neuronal differentiation by natural compounds","volume":"17","author":"An","year":"2022","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.neuropharm.2024.110170_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0140-6736(02)07497-4","article-title":"Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study","volume":"359","author":"Bahn","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110170_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1515\/rns.2011.037","article-title":"Is it possible to improve neurodevelopmental abnormalities in Down syndrome?","volume":"22","author":"Bartesaghi","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-3806(84)90083-X","article-title":"Dendritic development in human occipital cortical neurons","volume":"315","author":"Becker","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110170_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pneurobio.2004.08.001","article-title":"On dendrites in Down syndrome and DS murine models: a spiny way to learn","volume":"74","author":"Benavides-Piccione","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib13","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1523\/JNEUROSCI.0534-10.2010","article-title":"Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome","volume":"30","author":"Bianchi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-0082(03)00002-9","article-title":"Roles of the mammalian subventricular zone in brain development","volume":"69","author":"Brazel","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib15","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","article-title":"Down syndrome","volume":"382","author":"Bull","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2024.110170_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9828397","article-title":"Micronized palmitoylethanolamide-polydatin reduces the painful symptomatology in patients with interstitial cystitis\/bladder pain syndrome","volume":"2019","author":"Cervigni","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2024.110170_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1523\/JNEUROSCI.1003-21.2021","article-title":"DSCAM deficiency leads to premature spine maturation and autism-like behaviors","volume":"42","author":"Chen","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib18","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1002\/jcp.27536","article-title":"Brain-derived neurotrophic factor promotes proliferation and progesterone synthesis in bovine granulosa cells","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118158","article-title":"Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT\/ERK1\/2\/STAT3-SOX2\/Snail signaling pathway","volume":"258","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jpp\/rgac105","article-title":"Therapeutically important bioactive compounds of the genus Polygonum L. and their possible interventions in clinical medicine","volume":"75","author":"Cherian","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40263-013-0089-3","article-title":"Prospects for improving brain function in individuals with down syndrome","volume":"27","author":"Costa","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2024.110170_bib22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.13958","article-title":"Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome","volume":"45","author":"Cremon","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2024.110170_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41431-020-00748-y","article-title":"Estimation of the number of people with Down syndrome in Europe","volume":"29","author":"de Graaf","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2024.110170_bib24","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1100\/tsw.2006.322","article-title":"Developmental defects in trisomy 21 and mouse models","volume":"6","author":"Delabar","year":"2006","journal-title":"Sci. World J."},{"key":"10.1016\/j.neuropharm.2024.110170_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112397","article-title":"Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: a multicentric randomized controlled trial","volume":"122","author":"Di Nardo","year":"2024","journal-title":"Nutrition"},{"key":"10.1016\/j.neuropharm.2024.110170_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn3314","article-title":"Down syndrome: the brain in trisomic mode","volume":"13","author":"Dierssen","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib27","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3109\/13880209.2013.792849","article-title":"Polydatin: a review of pharmacology and pharmacokinetics","volume":"51","author":"Du","year":"2013","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF00294247","article-title":"Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus","volume":"79","author":"Ferrer","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature06514","article-title":"Neurite arborization and mosaic spacing in the mouse retina require DSCAM","volume":"451","author":"Fuerst","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110170_bib30","first-page":"103","article-title":"Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations","volume":"9","author":"Gardiner","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.neuropharm.2024.110170_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2015.08.001","article-title":"Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome","volume":"82","author":"Giacomini","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110170_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1750-3639.2012.00624.x","article-title":"Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of Down syndrome","volume":"23","author":"Guidi","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0954422416000081","article-title":"Modulating adult neurogenesis through dietary interventions","volume":"29","author":"Heberden","year":"2016","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.neuropharm.2024.110170_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/1028415X.2019.1641995","article-title":"Differential inhibitory effects of resveratrol on excitotoxicity and synaptic plasticity: involvement of NMDA receptor subtypes","volume":"24","author":"Hsieh","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib36","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3389\/fimmu.2018.02527","article-title":"Polydatin prevents lipopolysaccharide (LPS)-Induced Parkinson's disease via regulation of the AKT\/GSK3\u03b2-Nrf2\/NF-\u03baB signaling Axis","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib37","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.3390\/molecules27196474","article-title":"Polydatin: pharmacological mechanisms, therapeutic targets, biological activities, and health benefits","volume":"27","author":"Karami","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2024.110170_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-3806(01)00224-3","article-title":"Genetic influence on phenotypic differentiation in adult hippocampal neurogenesis","volume":"134","author":"Kempermann","year":"2002","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.neuropharm.2024.110170_bib39","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2024.110170_bib40","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1523\/JNEUROSCI.12-04-01382.1992","article-title":"Functional classes of cortical projection neurons develop dendritic distinctions by class-specific sculpting of an early common pattern","volume":"12","author":"Koester","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.neuroimage.2018.12.043","article-title":"Neural histology and neurogenesis of the human fetal and infant brain","volume":"188","author":"Kostovi\u0107","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2024.110170_bib42","article-title":"Differential responses of Trans-Resveratrol on proliferation of neural progenitor cells and aged rat hippocampal neurogenesis","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110170_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0149-7634(03)00006-X","article-title":"Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence","volume":"27","author":"Laviola","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.110170_bib44","first-page":"123","volume":"vol. 296","author":"Lu","year":"2013"},{"key":"10.1016\/j.neuropharm.2024.110170_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154161","article-title":"Pharmacological effects of polydatin in the treatment of metabolic diseases: a review","volume":"102","author":"Luo","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2024.110170_bib46","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/bmc.693","article-title":"Determination of piceid in rat plasma and tissues by high-performance liquid chromatographic method with UV detection","volume":"20","author":"Lv","year":"2006","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.neuropharm.2024.110170_bib47","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cne.901670105","article-title":"Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study","volume":"167","author":"Marin-Padilla","year":"1976","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib49","doi-asserted-by":"crossref","first-page":"16637","DOI":"10.1523\/JNEUROSCI.2811-12.2012","article-title":"DSCAM contributes to dendrite arborization and spine formation in the developing cerebral cortex","volume":"32","author":"Maynard","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib50","article-title":"Subtle roles of down syndrome cell adhesion molecules in embryonic forebrain development and neuronal migration","volume":"8","author":"Mitsogiannis","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/syn.21888","article-title":"Chronic administration of resveratrol prevents morphological changes in prefrontal cortex and hippocampus of aged rats","volume":"70","author":"Monserrat Hernandez-Hernandez","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2024.110170_bib52","first-page":"2776","volume":"vol. 232","author":"Ni","year":"2017"},{"key":"10.1016\/j.neuropharm.2024.110170_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0197-4580(01)00263-9","article-title":"Olfactory impairment increases as a function of age in persons with Down syndrome","volume":"23","author":"Nijjar","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2024.110170_bib54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF01190834","article-title":"Bromodeoxyuridine immunohistochemical determination of the lengths of the cell cycle and the DNA-synthetic phase for an anatomically defined population","volume":"18","author":"Nowakowski","year":"1989","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib55","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.neuron.2016.01.042","article-title":"Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination","volume":"89","author":"Olmos-Serrano","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110170_bib56","first-page":"405","article-title":"Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study","volume":"29","author":"Pace","year":"2015","journal-title":"In Vivo"},{"key":"10.1016\/j.neuropharm.2024.110170_bib57","doi-asserted-by":"crossref","first-page":"18851","DOI":"10.1039\/C8RA03124J","article-title":"Uncovering the action mechanism of polydatin via network pharmacological target prediction","volume":"8","author":"Pan","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.neuropharm.2024.110170_bib58","article-title":"The regulation of cyclin D promoters - review","volume":"27","author":"Pawlonka","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.neuropharm.2024.110170_bib59","first-page":"141","article-title":"Normal and aberrant neuronal development in the cerebral cortex of human fetus and young infant","author":"Purpura","year":"1975","journal-title":"UCLA Forum Med. Sci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib60","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrn2719","article-title":"Evolution of the neocortex: a perspective from developmental biology","volume":"10","author":"Rakic","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"Faseb. J. : official publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/j.neuropharm.2024.110170_bib62","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00335-011-9357-z","article-title":"Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn","volume":"22","author":"Reinholdt","year":"2011","journal-title":"Mamm. Genome"},{"issue":"Suppl. 3","key":"10.1016\/j.neuropharm.2024.110170_bib63","first-page":"511","article-title":"Critical periods of vulnerabiliy for the developing nervpus system: evidence from humans and animal models","volume":"108","author":"Rice","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.neuropharm.2024.110170_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063134","article-title":"Dietary and protective factors to halt or mitigate progression of autoimmunity, COVID-19 and its associated metabolic diseases","volume":"22","author":"Ricordi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1534\/genetics.105.050898","article-title":"Perinatal loss of Ts65Dn Down syndrome mice","volume":"172","author":"Roper","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.neuropharm.2024.110170_bib66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/bs.pbr.2019.10.001","article-title":"Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome","volume":"251","author":"Rueda","year":"2020","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110170_bib67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s004010000230","article-title":"The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains","volume":"100","author":"Saito","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01480545.2024.2311287","article-title":"Preclinical toxicological assessment of polydatin in zebrafish model","author":"Schimith","year":"2024","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13578-020-00491-3","article-title":"Molecular and biological functions of resveratrol in psychiatric disorders: a review of recent evidence","volume":"10","author":"Shayganfard","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib70","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1713548114","article-title":"DSCAM-mediated control of dendritic and axonal arbor outgrowth enforces tiling and inhibits synaptic plasticity","volume":"114","author":"Simmons","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2024.110170_bib71","volume":"vol. 6","author":"Sloviter","year":"2012"},{"key":"10.1016\/j.neuropharm.2024.110170_bib72","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11101-018-9574-0","article-title":"Recent advances in chemistry, therapeutic properties and sources of polydatin","volume":"17","author":"\u015e\u00f6hreto\u011flu","year":"2018","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.neuropharm.2024.110170_bib73","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.cell.2013.05.002","article-title":"Dynamics of hippocampal neurogenesis in adult humans","volume":"153","author":"Spalding","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2024.110170_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.903729","article-title":"The challenging pathway of treatment for neurogenesis impairment in down syndrome: achievements and perspectives","volume":"16","author":"Stagni","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2017.07.026","article-title":"Neurogenesis impairment: an early developmental defect in Down syndrome","volume":"114","author":"Stagni","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2024.110170_bib76","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2016.07.031","article-title":"Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome","volume":"333","author":"Stagni","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110170_bib77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnbeh.2015.00265","article-title":"Timing of therapies for Down syndrome: the sooner, the better","volume":"9","author":"Stagni","year":"2015","journal-title":"Frontiers Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib78","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nbd.2014.12.005","article-title":"Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice","volume":"74C","author":"Stagni","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110170_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.expneurol.2017.08.018","article-title":"A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS","volume":"298","author":"Stagni","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110170_bib80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2019.05.005","article-title":"Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome","volume":"129","author":"Stagni","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110170_bib81","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11065-010-9148-4","article-title":"The basics of brain development","volume":"20","author":"Stiles","year":"2010","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110170_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(81)90314-0","article-title":"Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study","volume":"225","author":"Takashima","year":"1981","journal-title":"Brain Res."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2024.110170_bib83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2788.1994.tb00394.x","article-title":"Dendritic and histochemical development and ageing in patients with Down's syndrome","volume":"38","author":"Takashima","year":"1994","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.neuropharm.2024.110170_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917697010","article-title":"The dietary constituent resveratrol suppresses nociceptive neurotransmission via the NMDA receptor","volume":"13","author":"Takehana","year":"2017","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2024.110170_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9218738","article-title":"Polydatin: a critical promising natural agent for liver protection via antioxidative stress","volume":"2022","author":"Tang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2024.110170_bib86","doi-asserted-by":"crossref","first-page":"10137","DOI":"10.1002\/jcb.28297","article-title":"Polydatin suppresses the development of lung inflammation and fibrosis by inhibiting activation of the NACHT domain-, leucine-rich repeat-, and pyd-containing protein 3 inflammasome and the nuclear factor-\u03baB pathway after Mycoplasma pneumoniae infection","volume":"120","author":"Tang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2024.110170_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135763","article-title":"DSCAM\/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome","volume":"131","author":"Tang","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuropharm.2024.110170_bib88","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2005.08.023","article-title":"GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells","volume":"47","author":"Tozuka","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110170_bib89","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/hmg\/ddr033","article-title":"APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome","volume":"20","author":"Trazzi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2024.110170_bib90","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1213\/ANE.0b013e31825da0fb","article-title":"Resveratrol regulates N-methyl-D-aspartate receptor expression and suppresses neuroinflammation in morphine-tolerant rats","volume":"115","author":"Tsai","year":"2012","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2024.110170_bib91","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bbadis.2016.03.003","article-title":"The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model","volume":"1862","author":"Valenti","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2024.110170_bib92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1037\/0735-7044.116.1.85","article-title":"Extensive cytotoxic lesions of the rat retrosplenial cortex reveal consistent deficits on tasks that tax allocentric spatial memory","volume":"116","author":"Vann","year":"2002","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib93","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1124\/dmd.104.000885","article-title":"High absorption but very low bioavailability of oral resveratrol in humans","volume":"32","author":"Walle","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2024.110170_bib94","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1523\/JNEUROSCI.5746-12.2013","article-title":"Modeling transformations of neurodevelopmental sequences across mammalian species","volume":"33","author":"Workman","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib95","first-page":"213","article-title":"[Effect of polydatin on learning and memory and expression of NR2B in the prefrontal cortex of rats with chronic alcoholism]","volume":"27","author":"Xu","year":"2011","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"10.1016\/j.neuropharm.2024.110170_bib96","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12576-015-0421-4","article-title":"Neural stem cells and neuro\/gliogenesis in the central nervous system: understanding the structural and functional plasticity of the developing, mature, and diseased brain","volume":"66","author":"Yamaguchi","year":"2016","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110170_bib97","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/dneu.22080","article-title":"CREB participates in the IGF-I-stimulation cyclin D1 transcription","volume":"73","author":"Yan","year":"2013","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.neuropharm.2024.110170_bib98","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jss.2015.05.041","article-title":"Polydatin: a new therapeutic agent against multiorgan dysfunction","volume":"198","author":"Zeng","year":"2015","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.neuropharm.2024.110170_bib99","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cercor\/bhr097","article-title":"Early postnatal migration and development of layer II pyramidal neurons in the rodent cingulate\/retrosplenial cortex","volume":"22","author":"Zgraggen","year":"2012","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2024.110170_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2014.10.060","article-title":"DSCAM and DSCAML1 regulate the radial migration and callosal projection in developing cerebral cortex","volume":"1594","author":"Zhang","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110170_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112164","article-title":"Resveratrol (RV): a pharmacological review and call for further research","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2024.110170_bib102","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.bbadis.2016.09.003","article-title":"Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3","volume":"1863","author":"Zhang","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:58:19Z","timestamp":1730865499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":102,"alternative-id":["S0028390824003393"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110170","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110170"}}